Douglas Leipold
8PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 11, 2024
The HER2-directed antibody-drug conjugate DHES0815A in advanced and/or metastatic breast cancer: preclinical characterization and phase 1 trial results.Gail D Lewis, Guangmin Li, Jun Guo
|Apr 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides.Neelie Zacharias, Vladimir N Podust, Kimberly K Kajihara
|Apr 01, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer.Peiyin Wang, Liping L Sun, Robyn Clark
|Mar 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved Properties.Breanna S Vollmar, Chris Frantz, Melissa M Schutten
|Dec 04, 2020
An Anti-CD22-seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models.Shang-Fan Yu, Donna W Lee, Bing Zheng
|Nov 02, 2019
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity.Thomas H Pillow, Pragya Adhikari, Robert A Blake
Pageof 2
Frequent Collaborators
3 joint publications
Katherine R Kozak
2 joint publications
Andrew G Polson
2 joint publications
Robyn Clark
1 joint publications
Shabkhaiz Masih
1 joint publications
Brandon Latifi
1 joint publications
Randall C Dere
1 joint publications
Jintang He
1 joint publications
Dian Su
1 joint publications
Thomas H Pillow
1 joint publications
Melinda M Mulvihill
